Kyongchol Kim1,2*
1Theragen Bio Institute, Suwon, Gyeonggi-do, Republic of Korea
2Gangnam Mizmedi Hospital, Anti-aging Clinic, Seoul, Republic of Korea
김경철1,2*
1테라젠바이오연구소, 2강남미즈메디병원 항노화클리닉
The development of modern medicine leads to evidence-based medicine (EBM) from episodic treatment through experience and intuition, focusing on average diagnosis and treatment. However, in the future, based on large-scale genetic information, it will lead to individualized medicine. Clinical genomics, which assesses the risk of disease through genetic information, is no longer a strange story for primary care physicians who are interested in prevention as well as prevention. There are many limitations in the interpretation of knowledge and information itself, and there are many technical and ethical problems to be used for commercial purposes. However, I believe that the point that the primary medical practitioner understands and applies the contents accurately overcomes the limitations. In addition, Doctors majoring in family medicine, who have played a role to understand and explain the occurrence, prevention, and treatment of diseases, share and share clinical genomic knowledge and experience to promote disease prevention and health promotion through interactions of environment and genetics. I believe it will contribute.
Keywords: Preventive, Prediction, Personalized, Participatory, Clinical genomics, Health promotion
2018;4(2):128-133
Published on Nov 30, 2018
Mizmedi Hospital, Antiaging Center, Daechi 1-dong, Dokoro 452, Gangnam-gu, Seoul, Republic of Korea
Tel: +82-31-888-9320, Fax: +82-31-888-9440